Clinical and Economic Impact of an Organized Treatment Pathway on AFib Patient Management From the ER

Clinical and Economic Impact of an Organized Treatment Pathway on Atrial Fibrillation Patient Management From the Emergency Room

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04476524

Acronym

ER2EP

Enrollment

200

Registered

2020-07-20

Start date

2020-08-15

Completion date

2021-12-31

Last updated

2021-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Cardiac Arrhythmia

Keywords

Clinical and Economical impact, Treatment pathway, Emergency Room, Atrial Fibrillation

Brief summary

Investigators developed a multidimensional protocol for the management of AF in the emergency department. Investigators aimed to assess if this new ER AF management protocol would result in better outcomes compared to routine care.

Detailed description

Management variation such as selecting rate vs rhythm control, timing and need for thromboembolic treatment, ER vs inpatient treatment and cardiology consultation could lead to disparate care of patients. Therefore, there is a need for future studies to standardize practice leading to improved management, decreased rates of hospitalization and overall cost. Investigators developed a multidimensional protocol for the management of AF in the emergency department. Investigators aimed to assess if this new ER AF management protocol would result in better outcomes compared to routine care.

Interventions

OTHERQuality improvement

All patients with AF as primary problem treated with study protocol would be compared with historical cohort of AF patients who were treated with routine care in the ER. Patients will be followed up and outcomes will be compared between two groups at 1, 3, 6 and 12 months.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Consecutive patients \> 18 years of age who comes to the ER with AF as the primary diagnosis and is treated according to study protocol.

Exclusion criteria

* Patients with established cardiology or electrophysiology care.

Design outcomes

Primary

Measure	Time frame	Description
Cumulative resource utilization in dollars	15 months	Primary Outcome
Time to definitive therapy (AAD and or Ablation)	15 months	Primary Outcome
Number of Hospital/clinic visits	15 months	Primary Outcome

Countries

United States

Contacts

Primary ContactDonita Atkins

datkins@kchrf.com816-651-1969

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026